Social & Media

Social & Media

EPP Factsheet
Size: 345 KB

CLINUVEL take pride in connecting with as many people as possible online. Come join us in any of our channels listed below to keep up to date for latest company developments:
CLINUVELCLINUVEL The Photoprotection NetworkThe Photoprotection Network The Photoprotection ChannelThe Photoprotection Channel
@CLINUVELNews LinkedInLinkedIn InstagramInstagram
We also host a regular column, Sub Q: Under the skin, on our website.

SubQ: Under the Skin SubQ: Under the Skin

This is a regular series about the big issues that affect CLINUVEL and the broader biopharmaceutical sector, The column is written by Giles Delaney, an experienced business journalist who has worked for newspapers and magazines in the Asia Pacific for more than three decades. As a guest writer, Delaney retains full editorial freedom and his views are his own. Links to previous columns are listed below:

CLINUVEL takes pride in connecting with as many people as possible online. Join us on any of our social channels to keep up to date for latest company developments.

This is a regular series about the big issues that affect CLINUVEL and the broader biopharmaceutical sector, The column is written by Giles Delaney, an experienced business journalist who has worked for newspapers and magazines in the Asia Pacific for more than three decades. As a guest writer, Delaney retains full editorial freedom and his views are his own.

Philippe Wolgen of CLINUVEL PHARMACEUTICALS driven by competition

New Treatment Inspires Hope for the Battle Against Sun Allergy

Drug Offers Hope Against Disease Where Sunlight Causes Pain

Implanted drug improves tolerance of sunlight in rare condition

CLINUVEL welcomes the opportunity to hear from our stakeholders on social media, and our channels have been designed to provide news updates and share relevant information.

Click here to read our social media guidelines.